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Abstract 
Background:  Effective parental management of childhood eczema requires education and support to reduce 
disease severity and improve child quality of life. Self-efficacy is a key factor influencing effective chronic 
disease management. There are no published scales to measure parental self-efficacy in managing childhood 
eczema.  The Parental Self-Efficacy with Eczema Care Index (PASECI) was designed to measure parental self-
efficacy in managing childhood eczema as a pre- and post-intervention tool in the evaluation of a structured 
Eczema Education Programme (EEP). 
 
Objective: To develop and test the validity, reliability and sensitivity of a new outcome measure (PASECI) 
designed to assess parental self-efficacy in managing their child’s eczema to determine pre and post changes 
in educational intervention evaluation studies. 
 
Methods: PASECI was developed from literature, expert consultation and piloting of a 40-item prototype. 
The final 29-item scale is arranged on 4 subscales. Parents of children with eczema aged 0-16 years (n=242) 
attending the EEP were assessed at 1 week pre-EEP and 4 weeks post-intervention. Cronbach α and factor 
analyses were undertaken.  
 
Results: PASECI has face, content and construct validity. It is reliable, with high item internal consistency 
(Cronbach α > 0.87 in all domains). Factor analysis revealed 4 viable domains. It was sensitive to change for 
post intervention measures using Sign tests (p<0.001).  
 
Conclusions:  PASECI is a useful, valid, reliable and sensitive evaluative outcome measure of self-efficacy in 
parents managing childhood eczema.  
 
Key words: Education, childhood eczema, atopic eczema, parental management, self-efficacy, outcome 
measure, self-management 
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Introduction  
Atopic eczema (AE) affects up to 20% of children in developed countries 1. The quality of life impact of 
eczema can be high for both children and their families2. Effective parental management minimises disease 
severity and improves child and family quality of life 3.   This requires a degree of knowledge, skill 
and confidence from the parent; confidence is akin to the psychological concept of self-efficacy. Self-efficacy 
(SE) is a concept derived from Bandura’s Social Learning Theory that refers to an individual’s belief in their 
own capacity to positively affect their health behaviour 4,5. Reviews 6,7,8 and policy9 highlight the value of SE 
in effective self-management of chronic disease. However, a gap in the literature is evident since little 
attention has been given to its application within a dermatological context and the self-efficacy of carers, 
although there are exceptions 10. A systematic review of educational interventions for child eczema has 
revealed both a lack of theoretical underpinnings and methodological limitations11.  The development of an 
outcome measure of parental self-efficacy in eczema care provides a basis for evaluating interventions 
directed towards enhancing parental confidence in managing their child’s condition. This study set out to 
develop and then validate a tool to measure parental self-efficacy and test the feasibility of its clinical 
application through a wider study evaluating an Eczema Education Programme directed at supporting 
parents’ in managing their child’s eczema 12, 13.  
 
A recent systematic review11 found no controlled studies evaluating self-efficacy outcomes in the parental 
management of eczema to date. With the exception of a range of severity measures 14 the most frequently 
used outcome tools applied to evaluate clinical and research interventions for childhood AE, measure 
dermatology specific child15 and infant16 quality of life and family impact2. These child and family outcome 
tools measure quality of life impact but do not give an indication of the educational support needs of 
parents managing child eczema. Accurate assessment of parental education and support needs is a critical 
factor in ensuring that interventions are directed toward increasing the self-efficacy required to enable 
parents to manage their child’s AE as effectively as possible.   
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‘The General Self-Efficacy Scale (GSES) has been developed17 and validated18, 19 with large scale populations. 
It is useful for assessing an individual’s belief in how they can be self-efficacious. However, the items within 
the GSES lack specificity to clinical contexts 20, such as childhood eczema. A disease or domain-specific 
measure of perceived self- efficacy is likely to be more useful than a general measure as they will reveal 
specific deficits that will enable targeted and personalised support by the healthcare professional 20, 21. 
Examples of disease-specific parental self-efficacy scales include studies of parents of children with asthma22, 
preterm neonates23, children with chronic pain24 and with minor child illness25. Robust tool development 
continues on scales to measure self-efficacy to manage chronic disease26. 
 
The Parental Self-Efficacy with Eczema Care Index (PASECI) was developed as an outcome measure for a 
study investigating the feasibility and impact of a structured education programme, termed the Eczema 
Education Programme (EEP)12,  which was designed for parents of children with eczema. Through the initial 
phase of delivery of the EEP we planned to develop and validate this scale 13. The EEP service offered parents 
access to standardised, evidence-based eczema education delivered in both specialist centres and the 
community12.  The EEP sample provided the basis for the validation of the PASECI scale.  
 
Objective 
To develop and test the validity, reliability and sensitivity of a new outcome measure designed to assess 
parental self-efficacy in managing their child’s eczema and for use as a self-report outcome measure to 
determine pre and post changes in eczema educational intervention studies. 
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Materials and Methods   
 
Development and testing of the Index (PASECI) 
The design of PASECI was informed by Bandura’s theory of SE 5, guidance on construction of SE scales20, 21, 
and a review of published research studies that had employed a self-efficacy measurement scale 4, 22,23,24,25, 
26.  A literature review was used to enhance content and construct validity. Existing self-efficacy scales from 
clinical areas outside the dermatology field were reviewed for relevant questions, content and wording that 
was suitable for application to the context of parental management of child eczema management. From 
this review, a set of 40 questions relevant to the disease-specific aspects of personal efficacy in eczema 
care were developed and grouped into four theoretical domains. Face and content validity was achieved by 
circulating successive iterations of the scale with the EEP expert steering group until the 40 item prototype 
(V7) scale was produced (see Figure 1); this version was tested. Each item could be scored on an 11 point 
scale (0 = not confident to 10 = very confident) to increase the response options and ability to distinguish 
between smaller differences on the scale, as well as to avoid heaping at the mid-point, as can be found on 
five point scales 20. A total range of scores with the index is 0-400. The PASECI index provides a basis for 
measuring changes in parental efficacy with eczema care over time.  The 4 domains or sections of the 
prototype index, each with 9-11 questions are: 
 
1. Managing Medication: Q1-10 (10 questions) 
2. Managing eczema and symptoms: Q 11-19 (9 questions).  
3. Communicating with Health Care Professionals: Q20-29 (10 questions) 
4. Managing Personal Challenges when caring for a child with eczema: Q30-40                    
              (11 questions)  
Prior to commencement NHS Research Ethics and Research Governance approvals were secured for this 
service evaluation study. 
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Participants and sampling: A purposive or non-probability sample (described below) was selected from the 
EEP study respondents (n= 242 parents). All parents attending the EEP programme over a 19 month period 
(n=356) were invited to participate.   The inclusion criteria were the same as for the entry to the EEP, that is, 
1) parent of child (0-16) with an eczema diagnosis; 2) family understanding the English language; and 3) child 
attending host hospital services or lived in, or had a GP in the local primary care community.  
 The PASECI questionnaire was completed by the parents one week before attending the educational 
intervention (EEP) and 4 weeks post-intervention to enable measurement of any change in parental self-
efficacy. The modal sub-group were parents of infants (0-4 years), who constituted 88% of this sample. The 
study location was a large inner city UK metropolitan borough characterised by high levels of mobility, ethnic 
diversity and social deprivation.  
 
Statistical methods:   The Statistical Package for the Social Sciences (SPSS version 20) and the programming 
language ‘R’ (version 3.0.0) were used for the analyses to determine statistically the validity and reliability of 
the scale and the number of factors or domains that were being measured. Analysis was organised into five 
main stages:- 
i) Descriptive statistics were run on the 40 items of the PASECI. We examined the distribution of items 
(questions) or variables; allowing investigation of missing data, spread and the operation of any floor 
or ceiling effects.     
ii) Item (question) by item analysis of change was used to investigate any variable change before and 
after the EEP using Sign tests for the 40 pre-post-tests, as the data were  of an ordinal nature  
iii) Factor analysis was used to verify appropriateness of domains or sections within the index. This was 
applied to the pre-intervention data using the Principal Components Method, followed by Varimax 
rotation. Following the results of the first stage of analysis, 6 items (questions) with substantial 
proportions of missing data were excluded (10%). Only 34 of the 40 items were included in the initial 
factor analyses. After the initial results, a further reduction to 29 items was made, fixing the number 
of factors extracted at four. As a further check on the consistency of the factor solution, the Maximum 
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Likelihood and Principal Axes Methods of factor extraction were applied to the list of 29 items. 
Following factor analysis we transferred two items to new domains in the prototype scale, producing 
the final scale; this produced a scale with a reduced number of questions, within each of the four 
domains of the index. 
iv) Reliability analysis involved examining the internal consistency of items; this was undertaken on the 
final scale using the Cronbach alpha statistic. 
v) Correlations were used to investigate convergent validity with domain total scores calculated for the 
final scale; this involved examining the relationship of parental self-efficacy to both child eczema 
severity and their quality of life. For cases pertaining to 0-4 year old (infants) only, Pearson correlations 
were calculated between these four domain total scores of the PASECI and the Patient Orientated 
Eczema Measure (POEM)27, Infant Dermatitis Quality of Life (IDQOL) Index 16.  
 
Results 
The following results derive from the five stages of analysis within the validation process and as such are 
presented in corresponding sequence. This data relates to the 242 parental cases, who were representative 
of the sample of parents attending the EEP 12. The actual sample size for each element of the analysis varied 
because of missing item data and the smaller number of available cases after education was delivered.  
 
(i) Descriptive statistics: Across all questions in our original prototype index of 40 items, the median scores 
ranged from 5-9, with lower quartiles ranging from 2-6 and upper quartiles from 8-10 (the maximum possible 
item rating).  The mode was the maximum possible rating of 10 for over half of the items. However, there 
were no floor or ceiling effects so all items were useful for discriminating between participants. Six items had 
missing data for at least 25 (10%) out of 242 cases: these related to the child’s engagement in their care, which 
would be more limited for infants (questions (Q) 12, 13, 14, 16), telling the nurse when you disagree with them 
(Q26) and the impact of feeling under pressure from work (Q31) due to the possibility of not being in paid 
work.   
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ii) Scale’s sensitivity to change: After controlling for multiple testing by setting a significance level of 0.1%, a 
significant improvement (p<0.001) was found for all 40 items (number analysed ranged from n=93 to 130). 
The pre-intervention responses for some items were skewed towards the top end of the scales and so little 
improvement was possible.  These results indicate that the PASECI is sensitive to change.  
 
iii) Factor analysis and structure of the scale: From the initial factor analysis of 34 items, extracting all factors 
with eigenvalues >1 produced 5 factors. However, as the fifth eigenvalue only marginally exceeded 1, we 
concluded that a four-factor solution (an index of four domains) is a good representation of the PASECI items. 
The pairwise correlation matrix of items revealed strong correlations between items within, with all exceeding 
0.75, (‘Managing medication’ domain (Q8-10) and the ‘Communicating with health professionals’ domain 
Q21-24 and Q28-29). This led to further examination of face validity, suggesting that those items 
differentiating health professionals might be redundant. The final 29 item questionnaire has removed items 
containing the terms ‘nurse’ or ‘doctor or GP’ and amended the language to refer to the generic term ‘health 
professional’. The four factor model loadings for the reduced set of 29 items are presented (see Table 1); those 
<0.4 were omitted. In summary, the factor analysis revealed that the four factor or domain structure of the 
index or scale was appropriate and viable, there was scope to reduce the number of items (questions) to 29 
and there was no need to have questions differentiating between different health professionals. A review of 
items following factor analysis highlighted opportunities to move some items to more appropriate domains. 
The final 29-item scale is given in Figure 2.  
 
iv) Reliability (internal consistency) of scale items: Cronbach’s alphas for the final 29 item scale with two 
transferred items are 0.906, 0.874, 0.915 and 0.953 for the respective domains; ‘Managing medication’, 
‘Managing eczema and symptoms’, ‘Communicating with health care professionals’ and ‘Managing personal 
challenges’ domain. These are all very good correlations that indicated high levels of internal consistency 
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between the items or questions. In no cases were significant increases obtained by removal of items from a 
domain.  
 
v) Correlations of parental self-efficacy and other outcome measures child outcomes: Table 2 presents sample 
correlations and confidence intervals between the total scores over items within each of the four PASECI 
domains in the final 29 item scale and the POEM (patient orientated severity measure) and IDQOL (infant 
quality of life) scale totals to explore convergent validity with other measures (self-reported (proxy) eczema 
symptom severity and quality of life respectively). As Q12, 13, 14 and 16 were removed from the original 40-
item PASECI and are potentially relevant to older children, only cases pertaining to children aged 0-4 were  
included in this analysis.  All correlations in Table 2 are very weak and so the convergent validity of the PASECI 
domain scores with a common measure of eczema severity and quality of life has not yet been established.   
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Discussion 
The PASECI scale has face, content and construct validity and reliability (internal consistency). Convergent 
validity with other common quality of life and disease severity measures was not established.  In the final 29-
item scale, the rigour and usability of the tool was improved by removing items not relevant to infants (the 
modal group) and collapsed to unifying responses to questions relating to engaging with health professionals, 
rather than differentiating the type, due to indications that the factor structure would be the same. The data 
indicates that the PASECI is sensitive to change. During the testing period linked to the EEP evaluation 
quantitative data was collected alongside qualitative from focus groups on parental self-efficacy with eczema 
care. Focus group (qualitative) data from parents’ post-intervention, showed clear themes, revealing 
enhancement of self-efficacy, when PASECI was used as an outcome measure, strengthening the indications 
of validity13. This combination of data (triangulation) was used to enhance the validity of the tool.  Factor 
analysis clearly revealed that items in three domains or sections of the index held up giving a factor structure 
of three factors ‘Managing Eczema and Symptoms’, ‘Communicating with Health Care Professionals’ and 
‘Managing Personal Challenge’s and indicated sufficient viability to retain the fourth (remaining) domain, 
‘Managing Medication’.   
 
The only similar and theoretically relevant outcome measure reported in dermatology was a German self-
efficacy scale (SEND) for parents of pre-school children with AE29. The validity of SEND questionnaire’s 9 
items were informed by theoretical concepts and parental interviews. It is claimed to be valid and reliable; 
however, the scale was not published in the paper and thus it is difficult to adequately appraise. Also, its use 
in English language countries is not established.  Hence the PASECI tool addresses a gap in the literature on 
self-efficacy scales applied to the dermatology field. Specifically, it provides an effective method to  assess 
parental education needs and to evaluate the impact of interventions designed to promote effective 
management of their child’s eczema.  
 
Analysis of some items from the prototype 40-item PASECI V7 was undertaken by Mitchell and Fraser.30 
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They sought to develop a suite of valid and reliable research instruments to appraise parents’ self-efficacy 
for performing AE management tasks, outcome expectations of such tasks, and self-reported task 
performance in a community sample of parents of children with AE. The validity and reliability of PASECI 
was additionally confirmed in Mitchell and Fraser’s analysis, however, their analysis excluded the domain 
‘Managing personal challenges’ and as such this process was incomplete30.   
 
The scale validation process has several limitations. Despite the demonstrable strengths in validity and 
reliability, further investigation of inter-relationship (convergence validity) between PASECI and DFI scores, 
and clinical severity is required to more fully test its relationship to other commonly used and potentially 
related measures of quality of life and clinical severity. One possible explanation for the lack of convergent 
validity reported  from our wider study previously11  is that disease severity was not a criterion for access 
to EEP and the quality of life impact we reported at baseline was low-moderate. Another explanation may 
be linked to the observation that many of the newly diagnosed infants did not have severe eczema. 
Another limitation is that there is reliance on self-reported data, which may affect the fidelity of the 
results. The generalizability of the findings is potentially confined to a UK metropolitan population, 
although validity of 25 of the main scale items has been established within an Australian study30. Although 
the PASECI can be effectively used to measure changes in parental self-efficacy with eczema care, further 
developmental work is required on the categorisation of high and low PASECI score bandings to enhance 
the index’s utility.  
 
The PASECI is of value as an outcome measure in studies designed to test the effectiveness of structured 
education or other interventions to improve parents’ management of their child’s eczema13. The final 
PASECI could be usefully applied by clinicians as an assessment and evaluation scale in the dermatology 
setting. By obtaining a baseline measure of parental self-efficacy to manage their child’s AE, they could 
target self-efficacy focused interventions, such as parental teaching about medications, to those with low 
self-efficacy baseline scores.  
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A recent and comprehensive review of self-efficacy interventions8 and a robust study26 by the same group 
highlights the significant potential of self-efficacy based programmes to improve the quality of life of 
patients with chronic diseases. We contend that the recommendations made are of equal relevance to 
parents of children with chronic skin diseases, such as eczema, as they have a key role in their effective 
management. Accurate measurement of parental self-efficacy and the evaluation of self-efficacy based 
interventions are of high importance in the promotion of effective management of childhood chronic 
dermatoses. Assessment of parental self-efficacy with eczema care provides a basis for enhancing 
concomitant educational support to the use of existing therapy that requires self-management. 
 
Acknowledgements:  
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Figure 1: Parental Self-Efficacy with Eczema Care Index prototype: 40 item (‘V7’) scale  
 
PARENTAL SELF-EFFICACY WITH ECZEMA CARE INDEX prototype: 40 items (‘V7’) scale 
 
      0          1          2          3          4         5          6         7         8          9        10 
Cannot                                                                                                          Highly  
do at all                                                                                                    certain can do 
 
MANAGING MEDICATION  
How confident do you feel that you can: 
1. Choose a moisturiser (grease) that is suitable for your child.                               
2.    Successfully apply moisturisers (grease) to your child's eczema.                      
3.   Successfully apply antibiotic creams to your child's eczema                        
4.   Correctly use steroid creams for your child.                                 
5.   Make the right choice of medication if the symptoms of your child's eczema become worse.              
6.  Know what to do if you think your child's eczema has become infected. 
7.  Judge whether the treatments/medication for your child's eczema works.              
8.  Ask a GP if you want to change your child's medications.                                  
9.  Ask a specialist if you want to change your child’s medications.                                                  
10. Ask the nurse/health visitor if you want to change your child's medications.         
MANAGING ECZEMA AND SYMPTOMS  
How confident do you feel that you can: 
11. Manage your child’s scratching behaviour so as to stop further skin damage.  
12. Help your child get involved in managing their eczema.                                                                                    
13. Be successful in getting your child to follow his/her management plan even when s/he may be reluctant. 
14. Help your child fit his/her eczema into a normal lifestyle.                                  
15. Manage to avoid things that irritate / aggravate your child's eczema.                 
16. Adjust your child’s management plan to allow for changes in your family’s schedule.    
17. Control your child's eczema so that he/she can play like other children.             
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18. Manage your child's eczema so that his/her symptoms are under control.             
19. Reduce any sleep disturbance brought about by your child's eczema.                 
COMMUNICATING WITH HEALTH CARE PROFESSIONALS  
How confident do you feel that you can: 
20. Get access to a health care professional if you need to speak to them about your child’s eczema.                                                                                          
21. Tell the GP when your child's eczema is not getting better.                              
22. Tell the nurse/health visitor when your child's eczema is not getting better.    
23. Ask the GP to explain things when you don't understand.                                    
24. Ask the nurse/health visitor to explain things when you don't understand.         
25. Tell the GP when you disagree with him/her.                                                      
26. Tell the nurse/health visitor when you disagree with him/her.           
27. Decide when to call in help from the GP or nurse.                                             
28. Ask to see a specialist doctor.                                                 
29. Ask to see a specialist nurse.                                                  
 MANAGING PERSONAL CHALLENGES WHEN CARING FOR YOUR CHILD WITH ECZEMA   
How confident do you feel that you can manage your child’s eczema in these situations?  
30. When I am feeling tired.           
31. When I am feeling under pressure from work.                         
32. During or after experiencing personal or family problems.                     
33. When I am feeling low or anxious.                                                     
34. When I am feeling ill.                         
35. Without support from my family or friends.     
36. During a holiday.                       
37. When I have too much housework/childcare to do at home        
38. When I have other time commitments     
16 
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39. When it’s difficult to get the prescribed creams        
40. When it’s difficult to get the right clothes for my child     
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Figure 2: Parental Self-Efficacy with Eczema Care Index: Final 29 item scale  
 
PARENTAL SELF-EFFICACY WITH ECZEMA CARE INDEX (PASECI)  
 
MANAGING MEDICATION:  How confident do you feel that you can: 
 
      0          1          2          3          4         5          6         7         8          9        10 
Cannot                                                                                                          Highly  
do at all                                                                                                    certain can do 
 
1. Choose a moisturiser (grease) that is suitable for your child [  ]           
 
2.  Successfully apply moisturisers (grease) to your child's eczema.                      
          
3.  Successfully apply antibiotic creams to your child's eczema                             
     
4.  Correctly use steroid creams for your child. 
                                                                 
5.  Make the right choice of medication if the symptoms of your child's eczema become worse. 
                
6.  Judge whether the treatments/medication for your child's eczema works.        
                 
MANAGING ECZEMA AND SYMPTOMS: How confident do you feel that you can: 
 
7. Manage your child’s scratching behaviour so as to stop further skin damage.   
            
8. Manage to avoid things that irritate / aggravate your child's eczema.                 
           
9. Control your child's eczema so that he/she can play like other children.             
           
10. Manage your child's eczema so that his/her symptoms are under control.           
                 
11. Reduce any sleep disturbance brought about by your child's eczema.                 
      
12.  Know what to do if you think your child's eczema has become infected. 
                                              .   
COMMUNICATING WITH HEALTH CARE PROFESSIONALS: How confident do you feel that you can: 
 
13. Get access to a health care professional if you need to speak to them about your child’s eczema.                                                                                          
             
14. Tell the health professional when your child's eczema is not getting better.                              
            
15. Ask the health professional to explain things when you don't understand.                                 
      
16. Tell the health professional when you disagree with him/her.                                                      
                       
17. Decide when to call in help from the health professional or nurse.                                             
             
18. Ask to see a specialist doctor.                                                 
 
19.  Ask a health professional if you want to change your child's medications.                                  
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MANAGING PERSONAL CHALLENGES WHEN CARING FOR YOUR CHILD WITH ECZEMA:   
How confident do you feel that you can manage your child’s eczema in these situations?  
 
20. When I am feeling tired.           
                                                                                   
21. During or after experiencing personal or family problems.                     
                    
22. When I am feeling low or anxious.                                                     
                       
23. When I am feeling ill.                         
                                                                         
24. Without support from my family or friends.     
                                                          
25. During a holiday.                       
                                                                                   
26. When I have too much housework/childcare to do at home        
                                
27. When I have other time commitments     
                                                                    
28. When it’s difficult to get the prescribed creams        
                                                  
29. When it’s difficult to get the right clothes for my child     
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Table 1: Factor loadings after Varimax rotation with a forced four factor solution for the 29 item Parental 
Self-Efficacy with Eczema Care Index (PASECI) (n=208) from children aged 0-16 years who took part in the 
Eczema Education Programme, London 2009-11  (nb: the numbers are not consecutive but reflect those 
drawn from the original 40 item prototype) 
Item Factor 
1 
Factor 
2  
Factor 
3 
Factor 
4 
Managing medication     
1. Choose a moisturiser (grease) that is suitable for your child   .413 .534 
2. Successfully apply moisturisers (grease) to your child’s 
eczema 
   .740 
3. Successfully apply antibiotic creams to your child’s eczema    .789 
4. Correctly use steroid creams for your child    .793 
5. Make the right choice of medication if the symptoms of your 
child’s eczema become worse 
  .593 .565 
6. Know what to do if you think your child’s eczema has 
become infected 
  .605  
7. Judge whether the treatments/medication for your child’s 
eczema works 
   .577 
8. Ask a GP if you want to change your child’s medications  .579  .407 
 Managing eczema and symptoms     
11. Manage your child’s scratching behaviour so as to stop 
further skin damage 
  .732  
15. Manage to avoid things that irritate/aggravate your child’s 
eczema 
  .569  
17. Control your child’s eczema so that he/she can play like other   .556  
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children 
18. Manage your child’s eczema so that his/her symptoms are 
under control 
  .683  
19. Reduce any sleep disturbance brought about by your child’s 
eczema 
  .604  
Communicating with health care professionals     
20. Get access to a health care professional if you need to speak 
to them about your child’s eczema 
 .607   
21. Tell the GP when your child’s eczema is not getting better  .783   
23. Ask the GP to explain things when you don’t understand  .760   
25. Tell the GP when you disagree with him/her  .709   
27. Decide when to call in help from the GP or nurse  .728   
28. Ask to see a specialist doctor  .695   
Managing personal challenges when caring for your child with 
eczema 
    
30. When I am feeling tired .792    
32. During or after experiencing personal or family problems .810    
33. When I am feeling low or anxious .828    
34. When I am feeling ill .805    
35. Without support from my family or friends .729    
36. During a holiday .682    
37. When I have too much housework/childcare to do at home .809    
38. When I have other time commitments .760    
39.  When it’s difficult to get the prescribed creams .589  .441  
40. When it’s difficult to get the right clothes for my child .581    
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Initial eigenvalue 14.927 2.271 1.538 1.257 
Percentage of variance explained 51.471 7.830 5.303   4.333 
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Table 2: Pearson correlations, 95% confidence intervals and sample sizes showing the correlation between 
the Infant Dermatitis Quality of Life (IDQOL) index and Patient Orientated Eczema Measure (POEM) and 
the four domains of the Parental Self-Efficacy with Eczema Care Index (PASECI) 1 on the final 29 item scale, 
from children aged 0-4 years who took part in the Eczema Education Programme, London 2009-11  
 
 Managing 
Medication 
Managing 
Symptoms 
Communication Personal 
Challenges 
IDQOL 2 -.146  
(-.280,-.007)  
(n=198) 
-.114  
(-.247,.024) 
(n=204) 
-.110  
(-.243,.026)  
(n=207) 
-.212  
(-.342,-.073) 
(n=195) 
POEM 2 -.030  
(-.258,.202) 
(n=73) 
-.092  
(-.312,.137) 
(n=75) 
-.115  
(-.332,.113)  
(n=76) 
-.151  
(-.373,.087)  
(n=70) 
1. The higher PASECI score the greater the parental self-efficacy  
2. The higher the quality of life score the worse the qol impact (IDQOL) or disease severity (POEM) 
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